Jump to Main Contents
研究所ロゴ

Home > Organization > Fundamental Innovative Oncology Core(FIOC) > Department of Proteomics > Research Papers

Research Papers

2020年以降の論文リスト

MS関係

  1. Hata S, Saito H, Kakiuchi T, Fukumoto D, Yamamoto S, Kasuga K, Kimura A, Moteki K, Abe R, Adachi S, Kinoshita S, Yoshizawa-Kumagaye K, Nishio H, Saito T, Saido TC, Yamamoto T, Nishimura M, Taru H, Sobu Y, Ohba H, Nishiyama S, Harada N, Ikeuchi T, Tsukada H, Ouchi Y, *Suzuki T. Brain p3-Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β-peptide EMBO Mol Med. 2023 May 8;15(5):e17052.
  2. Muto H, Honda T, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Imai N, Ishizu Y, Maeda K, Ishikawa T, Adachi S, Sato C, Tsuji NM, Ishigami M, Fujishiro M, *Kawashima H. Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet. Nutrients. 2023 Mar 19;15(6):1473.
  3. Kato K, Okazaki S, Schmitt-Ulms C, Jiang K, Zhou W, Ishikawa J, Isayama Y, Adachi S, Nishizawa T, Makarova KS, Koonin EV, Abudayyeh OO, Gootenberg JS, *Nishimasu H. RNA-triggered protein cleavage and cell growth arrest by the type III-E CRISPR nuclease-protease. Science. 2022 Nov 25;378(6622):882-889.
  4. Li S, Ikeuchi K, Kato M, Buschauer R, Sugiyama T, Adachi S, Kusano H, Natsume T, Berninghausen O, Matsuo Y, Becker T, Beckmann R, *Inada T. Sensing of individual stalled 80S ribosomes by Fap1 for nonfunctional rRNA turnover. Mol Cell. 2022 Sep 15;82(18):3424-3437.
  5. Tirta YK, Adachi S, Perez CAG, Adhitama N, Nong QD, Natsume T, Kato Y, *Watanabe H. CELF1 represses Doublesex1 expression via its 5' UTR in the crustacean Daphnia magna. PLoS One. 2022 Oct 14;17(10).
  6. Maeda F, Kato A, Takeshima K, Shibazaki M, Sato R, Shibata T, Miyake K, Kozuka-Hata H, Oyama M, Shimizu E, Imoto S, Miyano S, Adachi S, Natsume T, Takeuchi K, Maruzuru Y, Koyanagi N, Jun A, *Yasushi K. Role of the Orphan Transporter SLC35E1 in the Nuclear Egress of Herpes Simplex Virus 1. J Viro. 2022 May 25;96(10).
  7. Kojima H, Yagi H, Kushige H, Toda Y, Takayama K, Masuda S, Morisaku T, Tsuchida T, Kuroda K, Hirukawa K, Inui J, Nishi K, Nakano Y, Tanaka M, Hori S, Hasegawa Y, Abe Y, Kitago M, Adachi S, Tomi M, Matsuura K, Mizuguchi H, *Kitagawa Y. Decellularized Organ-Derived Scaffold Is a Promising Carrier for Human Induced Pluripotent Stem Cells-Derived Hepatocytes. Cells. 2022 Apr 11(8):1258.
  8. Higashi H, Yagi H, Kuroda K, Tajima K, Kojima H, Nishi K, Morisaku T, Hirukawa K, Fukuda K, Matsubara K, Kitago M, Shinoda M, Obara H, Adachi S, Nishimura K, Natsume T, Tomi M, Soto-Gutierrez A, *Kitagawa Y. Transplantation of bioengineered liver capable of extended function in a preclinical liver failure model. Am J Transplant. 2022 Mar 22(3):731-744.
  9. Tajima K, Yagi H, Morisaku T, Nishi K, Kushige H, Kojima H, Higashi H, Kuroda K, Kitago M, Adachi S, Natsume T, Nishimura K, Oya M, *Kitagawa Y. An organ-derived extracellular matrix triggers in situ kidney regeneration in a preclinical model. NPJ Regen Med. 2022 Feb 7(1):18.
  10. Mohamed HMA, Takahashi A, Nishijima S, Adachi S, Murai I, Okamura H, Yamamoto T. CNOT1 regulates circadian behaviour through Per2 mRNA decay in a deadenylation-dependent manner. RNA Biol. 2022 Jan 19(1):703-718.
  11. Ninomiya K, Iwakiri J, Aly MK, Sakaguchi Y, Adachi S, Natsume T, Terai G, Asai K, Suzuki T, *Hirose T. m(6) A modification of HSATIII lncRNAs regulates temperature-dependent splicing. EMBO J. 2021 Aug 40(15):e107976.
  12. Perez CAG, Adachi S, Nong QD, Adhitama N, Matsuura T, Natsume T, Wada T, Kato Y, *Watanabe H. Sense-overlapping lncRNA as a decoy of translational repressor protein for dimorphic gene expression. PLoS Genet. 2021 Jul 17(7):e1009683.
  13. Mogi K, Kimura H, Kondo Y, Inoue T, Adachi S, *Natsume T. Automatic radioisotope manipulation for small amount of nuclear medicine using an EWOD device with a dimple structure. R Soc Open Sci. 2021 May 8(5):201809.
  14. Udagawa T, Seki M, Okuyama T, Adachi S, Natsume T, Noguchi T, Matsuzawa A, *Inada T. Failure to Degrade CAT-Tailed Proteins Disrupts Neuronal Morphogenesis and Cell Survival. Cell Rep. 2021 Jan 34(1):108599.
  15. Suzuki T, Adachi S, Kikuguchi C, Shibata S, Nishijima S, Kawamoto Y, Iizuka Y, Koseki H, Okano H, Natsume T, *Yamamoto T. Regulation of Fetal Genes by Transitions among RNA-Binding Proteins during Liver Development. Int J Mol Sci. 2020 Dec 21(23):9319.
  16. Kato A, Adachi S, Kawano S, Takeshima K, Watanabe M, Kitazume S, Sato R, Kusano H, Koyanagi N, Maruzuru Y, Arii J, Hatta T, *Natsume T, *Kawaguchi Y. Identification of a herpes simplex virus 1 gene encoding neurovirulence factor by chemical proteomics. Nat Commun. 2020 Sep 11(1):4894.
  17. Otsuka H, Fukao A, Tomohiro T, Adachi S, Suzuki T, Takahashi A, Funakami Y, Natsume T, Yamamoto T, Duncan KE, Fujiwara T. ARE-binding protein ZFP36L1 interacts with CNOT1 to directly repress translation via a deadenylation-independent mechanism. Biochimie. 2020 Jul 174:49-56.
  18. Ninomiya K, Adachi S, Natsume T, Iwakiri J, Terai G, Asai K, *Hirose T. LncRNA-dependent nuclear stress bodies promote intron retention through SR protein phosphorylation. EMBO J. 2020 Feb 39(3):e102729.

RPPA関係

  1. Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan B, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, and Ishimoto T. Stromal amelioration through PDGFRα/β dual blockade boosts the efficacy of anti-PD-1 immunotherapy in TGF-β signaling-driven fibrotic tumors. Cancer Res. 2023 Mar 2;83(5):753-770.
  2. Suzuki H, Mitsunaga S, Ikeda M, Aoyama T, Yoshizawa K, Yoshimatsu H, Kawai N, Masuda M, Miura T, Ochiai A. Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer. Cancers, Sep 28; 13(19):4842, 2021.
  3. Fujisawa R, Iwaya T, Endo F, Idogawa M, Sasaki N, Hiraki H, Tange S, Hirano T, Koizumi Y, Abe M, Takahashi T, Yaegashi M, Akiyama Y, Masuda M, Sasaki A, , Takahashi F, Sasaki Y, Tokino T, Nishizuka S. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer. Carcinogenesis. Sep 24; bgab088, 2021.
  4. Hirozane T, Masuda M, Sugano T, Sekita T, Goto N, Aoyama T, Sakagami T, Uno Y, Moriyama H, Sawa M, Asano N, Nakamura M, Matsumoto M, Nakayama R, Kondo T, Kawai A, Kobayashi E, Yamada T. Direct conversion of osteosarcoma to adipocytes by targeting TNIK. JCI Insight. Feb 8;6(3):e137245, 2021.
  5. Sugano T, Masuda M, Takeshita F, Motoi N, Hirozane T, Goto N, Kashimoto S, Uno Y, Moriyama H, Sawa M, Nagakawa Y, Tsuchida A, Seike M, Gemma A, Yamada T. Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846. Br J Cancer. Jan; 124(1):228-236, 2021.
  6. Uchihara T, Miyake K, Yonemura A, Komohara Y, Itoyama R, Koiwa M, Yasuda T, Arima K, Harada K, Eto K, Hayashi H, Iwatsuki M, Iwagami S, Baba Y, Yoshida N, Yashiro M, Masuda M, Ajani JA, Tan P, Baba H, Ishimoto T. Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance. Cancer Res. Aug 15; 80(16):3222-3235, 2020.
  7. Sugano T, Yoshida M, Masuda M, Ono M, Tamura K, Kinoshita T, Tsuda H, Honda K, Gemma A, Yamada T. Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma. Br J Cancer. doi: 10.1038/s41416-020-0821-y, 2020.
  8. Miyanaga A, Masuda M, Motoi N, Tsuta K, Nakamura Y, Nishijima N, Watanabe SI, Asamura H, Tsuchida A, Seike M, Gemma A, Yamada T. Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence. Lung Cancer. Jul; 145:85-94, 2020.
  9. Sekita T, Yamada T, Kobayashi E, Yoshida A, Hirozane T, Kawai A, Uno Y, Moriyama H, Sawa M, Nagakawa Y, Tsuchida A, Matsumoto M, Nakamura M, Nakayama R, Masuda M. Feasibility of targeting Traf2- and Nck-interacting Kinase in Synovial Sarcoma. Cancers, 12(5):E1258, doi: 10.3390/cancers12051258, 2020.